Review article · 2025 · Open access

Breaking down barriers: is intestinal mucus degradation by Akkermansia muciniphila beneficial or harmful?

Anna M. Tingler, Melinda Anne Engevik

Infection and Immunity, 93(9), e0050324 · Published 11 August 2025 · DOI 10.1128/iai.00503-24

Open full textCite this paper

In brief

“Breaking down barriers: is intestinal mucus degradation by Akkermansia muciniphila beneficial or harmful?” is a 2025 review article by Anna M. Tingler and Melinda Anne Engevik, published in Infection and Immunity. OpenAlex counts 66 citations as of 21 November 2026, which puts it in the top 2% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Infection and Immunity.

Citations
66
Most cited in
2026 (60)
Field-weighted impact
4.31
References
369
Authors
2

Abstract

Akkermansia muciniphila is a specialized mucin-degrading bacterium that plays a pivotal role in gut health and disease. This review examines the dualistic nature of A. muciniphila mucin degradation, exploring its potential benefits and risks. As a mucin specialist, A. muciniphila uses glycosyl hydrolases and mucinases to degrade mucins, producing metabolites like short-chain fatty acids (SCFAs), branched-chain fatty acids (BCFAs), succinate, and other compounds. These metabolites benefit host health and cross-feed other commensal microbes, such as butyrate producers. A. muciniphila levels are inversely correlated with several disease states, such as obesity, diabetes, and inflammatory states, and administration of A. muciniphila has been found by several groups to restore and maintain gut homeostasis. However, under certain conditions, such as low dietary fiber or conditions with an altered gut microbiota, excessive mucin degradation by A. muciniphila can compromise the mucus barrier, increasing susceptibility to inflammation, infection, and pathogenic overgrowth. Elevated A. muciniphila levels have been associated with various diseases and medications, including graft versus host disease (GVHD) and irradiation, and shown to exacerbate infections by enteric pathogens. The context-dependent effects of A. muciniphila and mucin degradation underscore the need for a nuanced understanding of its interactions with the host and microbial community. This review aims to provide a balanced perspective on the implications of gut microbial mucus degradation, highlighting that it can be good, and it can be bad depending on the context.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Tingler, A. M., & Engevik, M. A. (2025). Breaking down barriers: is intestinal mucus degradation by Akkermansia muciniphila beneficial or harmful? Infection and Immunity, 93(9), e0050324. https://doi.org/10.1128/iai.00503-24

MLA 9

Tingler, Anna M., and Melinda Anne Engevik. “Breaking down barriers: is intestinal mucus degradation by Akkermansia muciniphila beneficial or harmful?” Infection and Immunity, vol. 93, no. 9, 2025, p. e0050324. https://doi.org/10.1128/iai.00503-24.

Chicago

Tingler, Anna M. and Melinda Anne Engevik. 2025. “Breaking down barriers: is intestinal mucus degradation by Akkermansia muciniphila beneficial or harmful?” Infection and Immunity 93 (9): e0050324. https://doi.org/10.1128/iai.00503-24.

Harvard

Tingler, A. M. and Engevik, M. A. (2025) ‘Breaking down barriers: is intestinal mucus degradation by Akkermansia muciniphila beneficial or harmful?’, Infection and Immunity, 93(9), p. e0050324. doi:10.1128/iai.00503-24.

IEEE

A. M. Tingler and M. A. Engevik, “Breaking down barriers: is intestinal mucus degradation by Akkermansia muciniphila beneficial or harmful?,” Infection and Immunity, vol. 93, no. 9, p. e0050324, 2025, doi: 10.1128/iai.00503-24.

BibTeX

@article{tingler2025breaking,
  title     = {{Breaking down barriers: is intestinal mucus degradation by Akkermansia muciniphila beneficial or harmful?}},
  author    = {Tingler, Anna M. and Engevik, Melinda Anne},
  journal   = {Infection and Immunity},
  year      = {2025},
  volume    = {93},
  number    = {9},
  pages     = {e0050324},
  doi       = {10.1128/iai.00503-24},
  url       = {https://doi.org/10.1128/iai.00503-24}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health

  • Akkermansia muciniphila
  • mucin degradation
  • intestinal mucus barrier
  • gut microbiota
  • short-chain fatty acids
  • branched-chain fatty acids
  • succinic acid
  • cross-feeding

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Tingler, A. M., & Engevik, M. A. (2025). Breaking down barriers: is intestinal mucus degradation by Akkermansia muciniphila beneficial or harmful? Infection and Immunity, 93(9), e0050324. https://doi.org/10.1128/iai.00503-24

How many times has this paper been cited?

66 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Infection and Immunity: sign in and open the full text from this page.

Who wrote this paper?

Anna M. Tingler, Melinda Anne Engevik.

What is the DOI of this paper?

10.1128/iai.00503-24, permanently at https://doi.org/10.1128/iai.00503-24. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.